Strides Pharma Science Has Announced That Its Step-Down Wholly Owned Subsidiary, Strides Pharma Global Pte. Singapore, Has Received Approval For Ursodiol Tablets Usp, 250 Mg And 500 Mg From The United States Food &Amp; Drug Administration (Fda).The Product Is A Generic Version Of Urso, 250 Mg And Urso Forte Tablets 500 Mg, Of Allergan Sales, Llc.According To Iqvia Mat June 2020 Data, The Us Market For Ursodiol Tablets Usp, 250 Mg And 500 Mg Is Approximately Us$ 35 Million The Product Will Be Manufactured At The Company&Rsquo;S Flagship Facility At Bengaluru And Will Be Marketed By Strides Pharma Inc. In The Us Market.The Company Has 126 Cumulative Anda Filings With Us Fda Of Which 88 Andas Have Been Approved And 38 Are Pending Approval.Ursodiol Tablets Are Indicated For The Treatment Of Patients With Primary Biliary Cirrhosis (Pbc).
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!